American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

Published on by Peter Horwich

Peter Horwich BS.c H M.Ed MD FRCSC – Charleston, South Carolina

Practice Contact Information

Head and Neck Specialists – Charleston
9228 Medical Plaza Drive

Charleston
South Carolina
29406
United States

Phone:
Email:
Web Site: https://yourheadandneckspecialists.com/

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Dr. Horwich is a board certified head and neck surgical oncologist and reconstructive surgeon. Born in Halifax, Nova Scotia he completed undergraduate, medical school and Otolaryngology – Head and Neck Surgery residency at Dalhousie University School of Medicine. He then completed two clinical fellowships in head and neck cancer surgery and microvascular reconstruction – the Medical University of South Carolina in 2019 and Louisiana State University at Shreveport in 2020. He also completed a Masters degree in education in 2021.

Clinical Trials

Bibliography

Published on by Amanda Silver-Karcioglu

Amanda Silver Karcioglu – Skokie, Illinois

Practice Contact Information

NorthShore University HealthSystem – Teaching affiliate of the University of Chicago
9669 Kenton Avenue
Suire 206
Skokie
Illinois
60076
United States

Phone:
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research

Biography/Statement

Dr. Amanda Silver Karcioglu is a fellowship-trained endocrine head and neck surgeon who specializes in thyroid and parathyroid surgery, lymph node dissections and has additional expertise and interest in advanced and recurrent thyroid cancer, the use of near-infrared autofluorescence for parathyroid gland preservation and minimally invasive approaches including ultrasound guided techniques in the office.  Her clinical research interests are focused on the application of technology to thyroid and parathyroid surgery and the patient experience including clinical decision making and thyroid cancer survivorship. Upon graduating from Williams College and the Stritch School of Medicine-Loyola University Chicago, she completed residency training at the Harvard Combined Otolaryngology Residency Program and an endocrine head and neck surgery fellowship at the Massachusetts Eye and Ear – Harvard University.

Clinical Trials

Bibliography

Russell MD and Silver Karcioglu A. Thyroid Cancer Survivorship: The Patient Experience. Accepted for publication in the invited special series “Improved Quality of Life after Thyroid Surgery.” Annals of Thyroid. 2022

Sehnem L, Noureldine S, Avci S, Isiktas G, Elshamy M, Saito Y, Abdelhamid Ahmed AH, Tierney HT, Trinh LN, Silver Karcioglu A, Cheung AY, Otremba M, Krishnamurthy V, Heiden K, Jin J, Shin J, Siperstein A, Zafereo M, Tufano RP, Randolph GW, Kebebew E, Milas M, Duh QY, Berber E. A Multicenter Evaluation of Near-Infrared Autofluorescence Imaging of Parathyroid Glands in Thyroid and Parathyroid Surgery. Accepted for publication in Surgery. 2022

Orloff LA, Noel JE, Stack BC Jr, Russell MD, Angelos P, Baek JH, Brumund KT, Chiang FY, Cunnane MB, Davies L, Frasoldati A, Feng AY, Hegedüs L, Iwata AJ, Kandil E, Kuo J, Lombardi C, Lupo M, Maia AL, McIver B, Na DG, Novizio R, Papini E, Patel KN, Rangel L, Russell JO, Shin J, Shindo M, Shonka DC Jr, Karcioglu AS, Sinclair C, Singer M, Spiezia S, Steck JH, Steward D, Tae K, Tolley N, Valcavi R, Tufano RP, Tuttle RM, Volpi E, Wu CW, Abdelhamid Ahmed AH, Randolph GW. Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head Neck. 2022 Mar;44(3):633-660. doi: 10.1002/hed.26960. Epub 2021 Dec 23. PMID: 34939714.

Wu CW, Huang TY, Randolph GW, Barczyński M, Schneider R, Chiang FY, Silver Karcioglu A, Wojtczak B, Frattini F, Gualniera P, Sun H, Weber F, Angelos P, Dralle H, Dionigi G. Informed Consent for Intraoperative Neural Monitoring in Thyroid and Parathyroid Surgery – Consensus Statement of the International Neural Monitoring Study Group. Front Endocrinol (Lausanne). 2021 Dec 7;12:795281. doi: 10.3389/fendo.2021.795281. PMID: 34950109; PMCID: PMC8689131.

Silver Karcioglu A, Iwata AJ, Pusztaszeri M, Abdelhamid Ahmed AH, Randolph GW. The American Thyroid Association (ATA) integrates molecular testing into its framework for managing patients with anaplastic thyroid carcinoma (ATC): Update on the 2021 ATA ATC guidelines. Cancer Cytopathol. 2022 Mar;130(3):174-180. doi: 10.1002/cncy.22519. Epub 2021 Oct 7. PMID: 34618407.

Wu CW, Randolph GW, Barczyński M, Schneider R, Chiang FY, Huang TY, Karcioglu AS, Konturek A, Frattini F, Weber F, Liu CH, Dralle H, Dionigi G. Training Courses in Laryngeal Nerve Monitoring in Thyroid and Parathyroid Surgery- The INMSG Consensus Statement. Front Endocrinol (Lausanne). 2021 Jun 18;12:705346. doi: 10.3389/fendo.2021.705346. PMID: 34220726; PMCID: PMC8253252.

Dhillon VK, Silver Karcioglu A, Bloom G, Randolph G, Lango M. What the thyroid cancer patient wants to know: ThyCa survey by the American Head and Neck Society Endocrine Surgery Section. Head Neck. 2020 Sep;42(9):2496-2504. doi: 10.1002/hed.26185. Epub 2020 Jun 12. PMID: 32530116.

Hohman, MH, Silver AL, Henstrom D, Cheney M, Hadlock T.  The “power” brow lift: efficient correction of the paralyzed brow. ISRN Plastic Surgery. 2013; Article ID 735406 (http://dx.doi.org/10.5402/2013/735406)

Maturo S, Silver A, Nimkin K, Sagar P, Ashland J, van der Kouwe AJ, Hartnick C. MRI with synchronized audio to evaluate velopharyngeal insufficiency. Cleft Palate Craniofac J. 2012 Nov;49(6):761-3. doi: 10.1597/10-255. Epub 2011 Jul 8. PMID: 21740179.

Silver AL, Nimkin K, Ashland JE, Ghosh SS, van der Kouwe AJ, Brigger MT, Hartnick CJ. Cine magnetic resonance imaging with simultaneous audio to evaluate pediatric velopharyngeal insufficiency. Arch Otolaryngol Head Neck Surg. 2011 Mar;137(3):258-63. doi: 10.1001/archoto.2011.11. PMID: 21422310.

Lin HW, Silver AL, Cunnane ME, Sadow PM, Kieff DA. Lateral dermoid cyst of the floor of mouth: unusual radiologic and pathologic findings. Auris Nasus Larynx. 2011 Oct;38(5):650-3. doi: 10.1016/j.anl.2011.01.002. Epub 2011 Feb 21. PMID: 21334151.

Silver AL, Yager P, Purohit P, Noviski N, Hartnick CJ. Dexmedetomidine use in pediatric airway reconstruction. Otolaryngol Head Neck Surg. 2011 Feb;144(2):262-7. doi: 10.1177/0194599810391397. Epub 2010 Dec 21. PMID: 21493428.

Silver AL, Faquin WC, Caruso PA, Deschler DG. Follicular dendritic cell sarcoma presenting in the submandibular region in an 11 year-old. Laryngoscope. 2010;120 Suppl 4:S183. doi: 10.1002/lary.21647. PMID: 21225781.[Originally presented as a poster presentation, the Triological Society 2010 Combined Sections Meeting, Orlando, FL, February 4-7, 2010: Laryngoscope. 2010;120 Suppl 4:S183.]

Silver AL, Farkash EA, Pitman MB, Rocco JW. Rosai-Dorfman disease presenting in the oropharynx. Head Neck. 2011 Nov;33(11):1660-3. doi: 10.1002/hed.21446. Epub 2010 Jun 11. PMID: 20544818.

Silver AL, Masia R, Hasserjian RP, Deschler DG. Pathology quiz case 1. Diffuse large B-cell lymphoma (DLBCL). Arch Otolaryngol Head Neck Surg. 2010 Aug;136(8):840, 842-3. doi: 10.1001/archoto.2010.118-a. PMID: 20713768.

Silver AL, Lindsay RW, Cheney ML, Hadlock TA. Thin-profile platinum eyelid weighting: a superior option in the paralyzed eye. Plast Reconstr Surg. 2009 Jun;123(6):1697-1703. doi: 10.1097/PRS.0b013e3181a65a56. PMID: 19483568.

Shen CC, Silver AL, O’Donnell TJ, Fleming JC, Karcioglu ZA. Optic neuropathy caused by naso-orbital mass in chronic intranasal cocaine abuse. J Neuroophthalmol. 2009 Mar;29(1):50-3. doi: 10.1097/WNO.0b013e3181989adb. PMID: 19458577.

Shirazi MA, Silver AL, Stankiewicz JA. Surgical outcomes following the endoscopic modified Lothrop procedure. Laryngoscope. 2007 May;117(5):765-9. doi: 10.1097/MLG.0b013e3180337d7b. PMID: 17473665.

Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002 Aug 21;288(7):835-40. doi: 10.1001/jama.288.7.835. PMID: 12186600.

Published on by Anthony Nichols

Anthony Nichols – London, Ontario

Practice Contact Information

Western University
800 Commissioners Road East

London
Ontario
N6A 5W9
Canada

Phone: 5196858804
Email: [email protected]
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Dr. Anthony C. Nichols is a Full Professor with the Department of Otolaryngology-Head and Neck Surgery and with the Department of Oncology. He is Director of the Translational Head and Neck Cancer Research Program, Chief of Head and Neck Surgical Oncology and the Microvascular Surgery Fellowship Director.

He received his medical degree from the University of Toronto in 2003. He then interned at Massachusetts General Hospital from 2003-2004, before completing his residency at the Harvard Combined Otolaryngology Program in 2008. While still at Harvard, he received fellowship training in Head and Neck Oncology and microvascular reconstruction in 2009. Under the mentorship of Dr. Jim Rocco, he pursued basic science training in the field of molecular biology of head and neck cancers in parallel with his clinical training.

Dr. Nichols joined the staff at the Schulich School of Medicine & Dentistry, Western University as a Surgeon- Scientist in 2009, in order to establish the Translational Head and Neck Cancer Program. He has developed a multi-faceted program that introduces laboratory findings into the clinic, by way of early stage clinical trials. This group specifically studies the genetic makeup of head and neck squamous cell cancer and anaplastic thyroid cancer to see how those genes predict the response to targeted therapy and chemotherapy.

Dr. Nichols, in partner with Drs. Kevin Fung and John Yoo, established the first transoral robotic surgery (TORS) program in Canada in 2010, for the minimally invasive treatment of head and neck tumours. In partner with radiation oncologist Dr. David Palma, Dr. Nichols has run the only two completed randomized trials comparing transoral surgery with primary radiation for oropharyngeal cancer – ORATOR (Lancet Oncology 2019, Journal of Clinical Oncology 2022) and ORATOR 2 (JAMA Oncology 2022). He has also led or involved in the development of multiple other clinical trials in head and neck oncology in the context of the HEADSTART initiative, as an executive member of the the Canadian Clinical Trials Group, and as member of the NRG PULA group.

Dr. Nichols’ work with the Translational Head and Neck Cancer Research Program has led to the training of 45 students, and over $8.3 million of funding that has culminated in 148 publications.

Clinical Trials

Bibliography

Dr. Anthony C. Nichols is a Full Professor with the Department of Otolaryngology-Head and Neck Surgery and with the Department of Oncology. He is Director of the Translational Head and Neck Cancer Research Program, Chief of Head and Neck Surgical Oncology and the Microvascular Surgery Fellowship Director.

He received his medical degree from the University of Toronto in 2003. He then interned at Massachusetts General Hospital from 2003-2004, before completing his residency at the Harvard Combined Otolaryngology Program in 2008. While still at Harvard, he received fellowship training in Head and Neck Oncology and microvascular reconstruction in 2009. Under the mentorship of Dr. Jim Rocco, he pursued basic science training in the field of molecular biology of head and neck cancers in parallel with his clinical training.

Dr. Nichols joined the staff at the Schulich School of Medicine & Dentistry, Western University as a Surgeon- Scientist in 2009, in order to establish the Translational Head and Neck Cancer Program. He has developed a multi-faceted program that introduces laboratory findings into the clinic, by way of early stage clinical trials. This group specifically studies the genetic makeup of head and neck squamous cell cancer and anaplastic thyroid cancer to see how those genes predict the response to targeted therapy and chemotherapy.

Dr. Nichols, in partner with Drs. Kevin Fung and John Yoo, established the first transoral robotic surgery (TORS) program in Canada in 2010, for the minimally invasive treatment of head and neck tumours. In partner with radiation oncologist Dr. David Palma, Dr. Nichols has run the only two completed randomized trials comparing transoral surgery with primary radiation for oropharyngeal cancer – ORATOR (Lancet Oncology 2019, Journal of Clinical Oncology 2022) and ORATOR 2 (JAMA Oncology 2022). He has also led or involved in the development of multiple other clinical trials in head and neck oncology in the context of the HEADSTART initiative, as an executive member of the the Canadian Clinical Trials Group, and as member of the NRG PULA group.

Dr. Nichols’ work with the Translational Head and Neck Cancer Research Program has led to the training of 45 students, and over $8.3 million of funding that has culminated in 148 publications.

Published on by Wendell Yarbrough

Wendell Yarbrough – Chapel Hill, North Carolina

Practice Contact Information

170 Manning Drive
CB #7070 Haupt Building – G125
Chapel Hill
North Carolina
27599-7070
United States

Phone: 919 843 7091
Email: [email protected]
Web Site: https://www.med.unc.edu/ent/

Areas of surgical specialization in Head and Neck Surgery

Endocrine Surgery, Head and Neck Research, Head and Neck Surgeon

Biography/Statement

Wendell (Dell) Yarbrough was born and grew up in Winston-Salem, North Carolina before attending the University of North Carolina, Chapel Hill as a Morehead Scholar. After graduating with honors with a dual degree Chemistry and Zoology, he matriculated at the University of North Carolina at Chapel Hill School of Medicine attaining an MD with honors and distinction.

Dr. Yarbrough’s training in Otolaryngology/Head and Neck Surgery was also at the University of North Carolina at Chapel Hill School of Medicine where he was named the Nathan A. Womack Scholar in recognition of being the outstanding senior house officer. After completion of residency, he obtained a fellowship in Surgical Oncology under the direction of Drs. Edison Liu and Yue Xiong, and in 1996 was appointed Assistant Professor at the University of North Carolina at Chapel Hill School of Medicine.  At the turn of the millennium, he was awarded the Jefferson Pilot Fellowship recognizing promising junior faculty at UNC School of Medicine.  In 2001, Dr. Yarbrough was promoted to Associate Professor with tenure, and in 2003, he relocated to Vanderbilt University as Director of the Barry Baker Laboratory for Head & Neck Oncology and was later named the Barry Baker Professor. While at Vanderbilt University, Dr. Yarbrough attended the Vanderbilt-Owens School of Management earning a Masters of Management in Healthcare (MMHC). In 2012, Dr. Yarbrough was appointed the Section Chief of Otolaryngology at Yale where he also served as the Director of the Head & Neck Disease Center in the Smilow Cancer Hospital and Co-Director of the Virus and Other Infection-associated Cancers (VOIC) Program at the Yale Cancer Center.  Dr. Yarbrough served on the Smilow Leadership Council and executive committee for the Yale Cancer Center. In 2017, he was awarded the Yale honorary master’s degree, the M.A. Privatim. In September of 2018, Dr. Yarbrough returned to UNC Chapel Hill School of Medicine as the Thomas J. Dark Distinguished Professor and Chair of the Department of Otolaryngology/Head and Neck Surgery.

Dr. Yarbrough is a diplomat of the American Board of Otolaryngology – Head & Neck Surgery (ABO-HNS) where he serves on the Executive Council. He has served on the Council of the American Head and Neck Society (AHNS) and on the Board of the Head and Neck Cancer Alliance (HNCA) and currently serves on the steering committee for the National Clinical Trials Network of the National Cancer Institute (NCI) and on the American Association of Cancer Research (AACR) Tobacco Products and Cancer Subcommittee. He has been an active Head & Neck Cancer Researcher for more than two decades with a current focus on human papilloma virus (HPV)-associated head and neck squamous cell carcinoma. Recent findings from the Yarbrough lab have been translated into clinical trials. His lab partners with Dr. Issaeva as founders of the Head & Neck Oncology Laboratory at UNC and are focused on prognostic biomarkers and developing new therapies.

Clinical Trials

LCCC 2044 : Prospective observational study to validate circulating HPVDNA and prognostic genomic biomarkers in HPV-associated OPSCC.

The purpose of the trial is to validate biomarkers for early detection of recurrent cancer and for determining which subset of patients with HPV-associated head and neck cancer have a better prognosis.  This information will be used to treat recurrences earlier and to select patients appropriate for less intensive or de-escalated therapy.

Bibliography

https://www.ncbi.nlm.nih.gov/myncbi/collections/mybibliography/

Published on by Chowdhury

Khal Chowdhury – Denver, Colorado

Practice Contact Information

Center for Craniofacial and Skull Base Disorders
1601 East 19th Avenue

Denver
Colorado
80218
United States

Phone: 303 839-5155
Email:
Web Site:

Areas of surgical specialization in Head and Neck Surgery

Head and Neck Research, Head and Neck Surgeon, Oral Surgeon, Reconstructive Head & Neck Surgery

Biography/Statement

Dr. K. Chowdhury MD, MBA, FACS, is board certified in both Otolaryngology-Head & Neck Surgery and Facial Plastic & Reconstructive Surgery. He has additional Fellowship training in Craniofacial & Skull Base Surgery.

His clinical practice interests include patients with salivary gland tumors, oral tumors, and maxillofacial oncology or jaw tumors, both benign and malignant. He has expertise in tumors of the skull base situated in difficult locations using both endoscopic minimally invasive and open approaches. He has a special interest in facial reconstructive surgery for maxillofacial fractures, and post cancer reconstruction. He is also very involved with Pediatric Head & Neck Surgery for tumors, and reconstruction for cleft lip & palate and congenital craniofacial anomalies (craniosynostoses). He seeks to understand and provide compassionate state of the art care for patients with complex and sometimes scary disorders of the head & neck and maxillofacial area.

 

Clinical Trials

Bibliography